Under-recognition and reporting of dengue in Cambodia: A capture-recapture analysis of the National Dengue Surveillance System

Epidemiology and Infection

Volumn 140, Issue 3, 2012, Pages 491-499

  Vong, S ^a   Goyet, S ^a   Ly, S ^a   Ngan, C ^b   Huy, R ^b   Duong, V ^a   Wichmann, O ^c   Letson, G W ^c   Margolis, H S ^c   Buchy, P ^a  

^a INSTITUT PASTEUR DU CAMBODGE   (Cambodia)

^b Ministry of Health Cambodia   (Cambodia)

^c International Vaccine Institute   (South Korea)

Author keywords

Active surveillance; Cambodia; capture recapture; cohort; dengue; national surveillance; underreporting

Indexed keywords

ADULT; AGE; ARTICLE; CAMBODIA; CHILD; CONTROLLED STUDY; DENGUE; DISEASE SURVEILLANCE; EPIDEMIC; FEMALE; FEVER; HOSPITAL PATIENT; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; RURAL AREA; SCHOOL CHILD; SEX DIFFERENCE; URBAN AREA;

ADOLESCENT; CAMBODIA; CHILD; CHILD, PRESCHOOL; DENGUE; EPIDEMIOLOGIC METHODS; FEMALE; HEALTH SERVICES RESEARCH; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; POPULATION SURVEILLANCE; YOUNG ADULT;

EID: 84856265390     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268811001191     Document Type: Article

References (34)

1. Gubler DJ, Clark G. Dengue/dengue hemorrhagic fever : the emergence of a global health problem. Emerging Infectious Diseases 1995; 1: 55-57.
2. Lang J. Recent progress on Sanofi Pasteur's dengue vaccine candidate. Journal of Clinical Virology 2009; 46 (Suppl. 2) : S20-S4.
3. Guy B, et al. Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirusprimed subjects. Vaccine 2008; 26: 5712-5721.
4. Sun W, et al. Phase 2 clinical trial of three formulations of tetravalent live-attenuated dengue vaccine in flavivirus-nave adults. Human Vaccines 2009; 5: 33-40.
5. Hombach J. Guidelines for clinical trials of dengue vaccine in endemic areas. Journal of Clinical Virology 2009; 46 (Suppl. 2) : S7-S9.
6. DeRoeck D, Deen J, Clemens JD. Policymakers' views on dengue fever/dengue haemorrhagic fever and the need for dengue vaccines in four Southeast Asian countries. Vaccine 2003; 22: 121-129. (Pubitemid 37357159)
7. Mahoney RT, et al. The introduction of new vaccines into developing countries. IV: Global access strategies. Vaccine 2007; 25: 4003-4011. (Pubitemid 46616993)
8. Huy R, et al. National dengue surveillance in Cambodia 1980-2008: epidemiological and virological trends and the impact of vector control. Bulletin of the World Health Organization 2010; 88: 650-657.
9. Hook EB, Regal RR. Capture-recapture methods. Lancet 1992; 339: 742.
10. Ministry of Planning, Government of Cambodia. General Population Census of Cambodia 2008, Provisional population totals. National Institute of Statistics, 2008.
11. Gallay A, et al. The capture-recapture applied to epidemiology: principles, limits and application. Revue d'Epidémioliogie et de Santé Publique 2002; 50: 219-232. (Pubitemid 34568318)
12. Hook EB, Regal RR. Recommendations for presentation and evaluation of capture-recapture estimates in epidemiology. Journal of Clinical Epidemiology 1999; 52: 917-926. (Pubitemid 29486557)
13. WHO. Dengue Haemorrhagic Fever: Diagnosis, Treatment, Prevention and Control, 2nd edn. Geneva: World Health Organization, 1997.
14. Vong S, et al. Dengue incidence in urban and rural Cambodia: results from population-based active Fever surveillance, 2006-2008. PLoS Neglected Tropical Diseases 2010; 4: e903.
15. Rossi CA, Ksiazek TG. Enzyme-linked immunosorbent assay (ELISA). In: Lee HW, Calisher C, Schmaljohn C, eds. Manual of Hemorrhagic Fever with Renal Syndrome and Hantavirus Pulmonary Syndrome. World Health Organization Collaborating Center for Virus Reference and Research (Hantaviruses), Seoul, Korea: Asian Institute for Life Sciences, 1999, pp. 8791.
16. Hunsperger EA, et al. Evaluation of commercially available anti-dengue virus immunoglubulin M tests. Emerging Infectious Diseases 2009; 15: 436-440.
17. Lanciotti RS, et al. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. Journal of Clinical Microbiology 1992; 30: 545-551.
18. Reynes JM, et al. Improved molecular detection of dengue virus serotype 1 variants. Journal of Clinical Microbiology 2003; 41: 3864-3867.
19. Finot L. Notre transcription du Cambodgien. Bulletin de l'Ecole franç aise d'Extrême-Orient 1902; 2: 1-15 (http://www.persee.fr/ web/revues/home/prescript/article/befeo-0336-1519-1902-num-2-1-1094).
20. WHO. Dengue: guidelines for diagnosis, treatment, prevention and control, new edition. Geneva, World Health Organization, 2009.
21. Anderson KB, et al. Burden of symptomatic dengue infection in children at primary school in Thailand: a prospective study. Lancet 2007; 369: 1452-1459. (Pubitemid 46635782)
22. Vaughn DW, et al. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. Journal of Infectious Diseases 2000; 181: 2-9. (Pubitemid 30049026)
23. Gibbons RV, et al. Analysis of repeat hospital admissions for dengue to estimate the frequency of third or fourth dengue infections resulting in admissions and dengue hemorrhagic fever, and serotype sequences. American Journal of Tropical Medicine and Hygiene 2007; 77: 910-913. (Pubitemid 351837840)
24. Ngan C, P Guyant, S Hoyer. Control of DHF outbreak in Cambodia, 1998. Dengue Bulletin 1998; 22: 69-74.
25. Hook EB, Regal RR. Capture-recapture methods in epidemiology: methods and limitations. Epidemiologic Reviews 1995; 17: 243-264. (Pubitemid 26096873)
26. Chao A, et al. The applications of capture-recapture models to epidemiological data. Statistics in Medicine 2001; 20: 3123-3157. (Pubitemid 32982533)
27. LaPorte RE, et al. Efficiency and accuracy of disease monitoring systems : application of capture-recapture methods to injury monitoring. American Journal of Epidemiology 1995; 142: 1069-1077.
28. Orton H, Rickard R, Miller L. Using active medical record review and capture-recapture methods to investigate the prevalence of Down Syndrome among live-born infants in Colorado. Teratology 2001; 64: S14-S19.
29. EURODIAB ACE Study Group. Variation and trends in incidence of childhood diabetes in Europe. Lancet 2000; 355: 873-876.
30. McClish D, Penberthy L. Using Medicare data to estimate the number of cases missed by a cancer registry : a 3-source capture-recapture model. Medical Care 2004; 42: 1111-1116. (Pubitemid 39472117)
31. Tilling K, Sterne JA, Wolfe CD. Estimation of the incidence of stroke using a capture-recapture model including covariates. International Journal of Epidemiology 2001; 30: 1351-1359. (Pubitemid 34134289)
32. Mahr A, et al. Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate. Arthritis and Rheumatism 2004; 51: 92-99. (Pubitemid 38222288)
33. van Hest NA, et al. Estimating infectious diseases incidence : validity of capture-recapture analysis and truncated models for incomplete count data. Epidemiology and Infection 2008; 136: 14-22.
34. Dechant EJ, Rigau-Pérez JG. Hospitalizations for suspected dengue in Puerto Rico, 1991-1995: estimation by capture-recapture methods. The Puerto Rico Association of Epidemiologists. American Journal of Tropical Medicine and Hygiene 1999; 61: 574-578. (Pubitemid 29506337)